Effect of Tong Luo Jiu Nao on Aβ-degrading enzymes in AD rat brains

Affholter, 1990, Insulin-degrading enzyme: stable expression of the human complementary DNA, characterization of its protein product, and chromosomal mapping of the human and mouse genes, Molecular Endocrinology, 4, 1125, 10.1210/mend-4-8-1125 Bates, 2009, Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests, Molecular Psychiatry, 14, 469, 10.1038/mp.2008.96 Bennett, 2000, Degradation of amylin by insulin-degrading enzyme, Journal of Biological Chemistry, 275, 36621, 10.1074/jbc.M006170200 Buoso, 2010, Beta-amyloid precursor protein metabolism: focus on the functions and degradation of its intracellular domain, Pharmacological Research, 62, 308, 10.1016/j.phrs.2010.05.002 Caccamo, 2005, Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders, Neurobiology of Aging, 26, 645, 10.1016/j.neurobiolaging.2004.06.013 Carson, 2002, Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?, Journal of Neurochemistry, 81, 1, 10.1046/j.1471-4159.2002.00855.x Chen, 2006, Reductions in levels of the Alzheimer's amyloid beta peptide after oral administration of ginsenosides, FASEB Journal, 20, 1269, 10.1096/fj.05-5530fje Cheng, 2010, Inhibition of phosphodiesterase-4 reverses memory deficits produced by Abeta25–35 or Abeta1-40 peptide in rats, Psychopharmacology, 212, 181, 10.1007/s00213-010-1943-3 Choi, 2007, Ameliorating effect of Gardenia jasminoides extract on amyloid beta peptide-induced neuronal cell deficit, Molecules and Cells, 24, 113 Cracchiolo, 2007, Enhanced cognitive activity – over and above social or physical activity – is required to protect Alzheimer's mice against cognitive impairment, reduce Abeta deposition, and increase synaptic immunoreactivity, Neurobiology of Learning and Memory, 88, 277, 10.1016/j.nlm.2007.07.007 Deane, 2009, Clearance of amyloid-beta peptide across the blood–brain barrier: implication for therapies in Alzheimer's disease, CNS & Neurological Disorders-Drug Targets, 8, 16, 10.2174/187152709787601867 Dorfman, 2010, Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease, Neurobiology of Aging, 31, 1743, 10.1016/j.neurobiolaging.2008.09.016 Duckworth, 1994, A direct inhibitory effect of insulin on a cytosolic proteolytic complex containing insulin-degrading enzyme and multicatalytic proteinase, Journal of Biological Chemistry, 269, 24575, 10.1016/S0021-9258(17)31430-8 Eisele, 2010, Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis, Science, 330, 980, 10.1126/science.1194516 El-Amouri, 2008, Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease, American Journal of Pathology, 172, 1342, 10.2353/ajpath.2008.070620 Farris, 2003, Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo, Proceedings of the National Academy of Sciences of the United States of America, 100, 4162, 10.1073/pnas.0230450100 Farris, 2007, Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy, American Journal of Pathology, 171, 241, 10.2353/ajpath.2007.070105 Hardy, 1997, Amyloid, the presenilins and Alzheimer's disease, Trends in Neurosciences, 20, 154, 10.1016/S0166-2236(96)01030-2 Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994 Hardy, 1992, Alzheimer's disease: the amyloid cascade hypothesis, Science, 256, 184, 10.1126/science.1566067 Hellstrom-Lindahl, 2008, Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels, Neurobiology of Aging, 29, 210, 10.1016/j.neurobiolaging.2006.10.010 Hersh, 1982, Degradation of enkephalins: the search for an enkephalinase, Molecular and Cellular Biochemistry, 47, 35, 10.1007/BF00241564 Hersh, 2008, Neprilysin and amyloid beta peptide degradation, Current Alzheimer Research, 5, 225, 10.2174/156720508783954703 Holcomb, 1998, Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes, Nature Medicine, 4, 97, 10.1038/nm0198-097 Hsiao, 1996, Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice, Science, 274, 99, 10.1126/science.274.5284.99 Hua, 2010, Brain microvascular endothelial cells mediate neuroprotective effects on ischemia/reperfusion neurons, Journal of Ethnopharmacology, 129, 306, 10.1016/j.jep.2010.03.024 Hyman, 1984, Alzheimer's disease: cell-specific pathology isolates the hippocampal formation, Science, 225, 1168, 10.1126/science.6474172 Iwata, 2005, Metabolism of amyloid-beta peptide and Alzheimer's disease, Pharmacology and Therapeutics, 108, 129, 10.1016/j.pharmthera.2005.03.010 Iwata, 2001, Metabolic regulation of brain Abeta by neprilysin, Science, 292, 1550, 10.1126/science.1059946 Iwata, 2000, Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition, Nature Medicine, 6, 143, 10.1038/72237 Jaya Prasanthi, 2008, Regulation of beta-amyloid levels in the brain of cholesterol-fed rabbit, a model system for sporadic Alzheimer's disease, Mechanisms of Ageing and Development, 129, 649, 10.1016/j.mad.2008.09.002 Kasturirangan, 2010, Targeted hydrolysis of Beta-amyloid with engineered antibody fragment, Current Alzheimer Research, 7, 214, 10.2174/156720510791050876 Klunk, 1999, Quantifying amyloid beta-peptide (Abeta) aggregation using the Congo red-Abeta (CR-abeta) spectrophotometric assay, Analytical Biochemistry, 266, 66, 10.1006/abio.1998.2933 Kurochkin, 1994, Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme, FEBS Letters, 345, 33, 10.1016/0014-5793(94)00387-4 Kwon, 2011, Neuroprotective effects of Eucommia ulmoides Oliv. bark on amyloid beta(25–35)-induced learning and memory impairments in mice, Neuroscience Letters, 487, 123, 10.1016/j.neulet.2010.10.042 Liu, 2010, Circulating neprilysin clears brain amyloid, Molecular and Cellular Neurosciences, 45, 101, 10.1016/j.mcn.2010.05.014 Marambaud, 2005, Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides, Journal of Biological Chemistry, 280, 37377, 10.1074/jbc.M508246200 Marr, 2004, Neprilysin regulates amyloid Beta peptide levels, Journal of Molecular Neuroscience, 22, 5, 10.1385/JMN:22:1-2:5 Maurice, 1997, Dehydroepiandrosterone sulfate attenuates dizocilpine-induced learning impairment in mice via sigma 1-receptors, Behavioural Brain Research, 83, 159, 10.1016/S0166-4328(97)86061-5 Maurice, 1996, Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction, Brain Research, 706, 181, 10.1016/0006-8993(95)01032-7 McDermott, 1997, Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme, Neurochemical Research, 22, 49, 10.1023/A:1027325304203 Miners, 2008, Abeta-degrading enzymes in Alzheimer's disease, Brain Pathology, 18, 240, 10.1111/j.1750-3639.2008.00132.x Miners, 2009, Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity, Journal of Neuropathology and Experimental Neurology, 68, 902, 10.1097/NEN.0b013e3181afe475 Miners, 2010, Changes with age in the activities of beta-secretase and the Abeta-degrading enzymes neprilysin, insulin-degrading enzyme and angiotensin-converting enzyme, Brain Pathology, 20, 794, 10.1111/j.1750-3639.2010.00375.x Misbin, 1989, Degradation of insulin and insulin-like growth factors by enzyme purified from human erythrocytes. Comparison of degradation products observed with A14- and B26-[125I] monoiodoinsulin, Diabetes, 38, 152, 10.2337/diab.38.2.152 Qiu, 2006, Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis, Neurobiology of Aging, 27, 190, 10.1016/j.neurobiolaging.2005.01.004 Qiu, 1998, Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation, Journal of Biological Chemistry, 273, 32730, 10.1074/jbc.273.49.32730 Rohn, 2008, Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2, Journal of Neuroscience, 28, 3051, 10.1523/JNEUROSCI.5620-07.2008 Schmitz, 2004, Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease, American Journal of Pathology, 164, 1495, 10.1016/S0002-9440(10)63235-X Van der Borght, 2007, Exercise improves memory acquisition and retrieval in the Y-maze task: relationship with hippocampal neurogenesis, Behavioral Neuroscience, 121, 324, 10.1037/0735-7044.121.2.324 Vepsalainen, 2009, Combined risk effects of IDE and NEP gene variants on Alzheimer disease, Journal of Neurology, Neurosurgery and Psychiatry, 80, 1268, 10.1136/jnnp.2008.160002 Wheeler, 2002, Regulation of synaptophysin degradation by mammalian homologues of seven in absentia, Journal of Biological Chemistry, 277, 10273, 10.1074/jbc.M107857200 Wolthuis, 1981, Behavioural effects of etiracetam in rats, Pharmacology, Biochemistry and Behavior, 15, 247, 10.1016/0091-3057(81)90184-2 Yang, 2009, Ginsenoside Rg3 promotes beta-amyloid peptide degradation by enhancing gene expression of neprilysin, Journal of Pharmacy and Pharmacology, 61, 375, 10.1211/jpp.61.03.0013 Yoshida, 2005, The potential role of amyloid beta in the pathogenesis of age-related macular degeneration, Journal of Clinical Investigation, 115, 2793, 10.1172/JCI24635 Zhang, 2006, Expression of BACE1 mRNA in Aβ1-40 induced AD in rats and the effect of TLJN Oral Solution, Pharmacology and Clinics of Chinese Materia Medica, 22, 50 Zhang, 2007, Effect of Tongluo Jiunao oral solution on learning and memory and the expression of AChE in hippocampus of AD rats, China Journal of TCM and Pharmacy, 22, 410